Inogen’s share price has performed poorly since I rated the stock a Buy in July 2023, and for good reason. Another round of senior executive changes combined with a questionable acquisition has ...
BEVERLY, Mass.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the ...
A month has gone by since the last earnings report for Inogen (INGN). Shares have added about 6.8% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results